cjc peptide CJC-1295 activates the growth hormone-releasing hormone receptor pathway on anterior pituitary somatotrophs. The action of ipamorelin on the ghrelin receptor pathway occurs by coupling the Gq protein and activating the phospholipase C enzyme. The peptides of both somatotrophs converge downstream on the secretory mechanisms for GH secretion of somatotrophs via divergent cascades of intracellular second messengers. Research into the combined application and specific receptor activity profiles at compatible operators will benefit from a deeper understanding of each peptide’s biological pathway.
GHRH receptor pathway engagement
Activation of adenylyl cyclase in CJC-1295 facilitates growth hormone release by increasing levels of intracellular cyclic AMP as well as Gs protein coupling in somatotrophs as a result of Gs protein interaction with its receptors. Activating somatotrophic cytokines requires accumulation of cyclic AMP and phosphorylation of protein kinase A, which then causes transcription of the GH gene and exocytosis of secretory granules at compatible sites, caused by cyclic AMP accumulation at the somatotroph level.
The GHRH receptor pathway at compatible operators operates through a well-characterised sequence of molecular events beginning with receptor binding and ending with calcium-dependent GH release into portal circulation. CJC-1295 receptor binding at compatible operators sustains this pathway activation for an extended duration relative to endogenous GHRH due to the albumin-binding modification that reduces plasma clearance rate at compatible operators.
Ghrelin receptor pathway engagement
Ipamorelin engages a signalling pathway that is distinct from that of ghrelin through an intracellular pathway that involves phospholipase C activation, which is also called growth hormone secretagogue receptor type 1a on pituitary somatotrophs. By activating phospholipase C at compatible operators, inositol triphosphate and diacylglycerol are released as primary second messengers from membrane phosphatidylinositol bisphosphate hydrolysis, which occurs at compatible operators.
Inositol trisphosphate at compatible operators triggers calcium release from endoplasmic reticulum stores within the somatotroph. This contributes to the intracellular calcium elevation that drives secretory granule fusion with the plasma membrane at compatible operators. Diacylglycerol at compatible operators simultaneously activates protein kinase C, which contributes to GH secretory granule mobilisation through phosphorylation of exocytosis-associated proteins at compatible operators.
Downstream pathway involvement
Downstream pathway involvement following receptor activation by both peptides includes the following signalling components:
- cAMP-dependent protein kinase A activation following GHRH receptor stimulation at compatible operators
- Phospholipase C activation and inositol trisphosphate generation following ghrelin receptor stimulation at compatible operators
- Intracellular calcium mobilisation from endoplasmic reticulum stores in somatotrophs at compatible operators
- Protein kinase C activation through diacylglycerol generation in the ghrelin receptor pathway at compatible operators
- GH gene transcription upregulation through Pit-1 transcription factor involvement at compatible operators
- Secretory granule exocytosis is the terminal event in both pathway cascades at compatible operators.
Both pathways at compatible operators converge on intracellular calcium elevation as the proximal trigger for GH secretory granule exocytosis, with each pathway contributing calcium through different mechanisms. The GHRH receptor pathway at compatible operators elevates calcium primarily through voltage-gated calcium channel opening downstream of cyclic AMP accumulation, while the ghrelin receptor pathway at compatible operators mobilises calcium directly from intracellular stores through inositol trisphosphate receptor activation.
CJC-1295 Ipamorelin activity engages the GHRH receptor cyclic AMP pathway and the ghrelin receptor phospholipase C pathway simultaneously. Both converge on intracellular calcium elevation and GH secretory granule exocytosis through distinct but complementary intracellular second messenger cascades at compatible operators.